Evidence map›Paper›PMID 37064165›Full record

ArticleMicrosystems & nanoengineering2023

Construction of multiple concentration gradients for single-cell level drug screening.

Shaofei Shen, Fangjuan Zhang, Yali Zhang, Yi Li, Yanbing Niu, Long Pang, Jinyi Wang

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shaofei Shen *Shanxi Key Lab for Modernization of TCVM, College of Life Science, Shanxi Agricultural University, Taigu, Shanxi 030801 China.ORCID 0000-0002-4350-5696
Fangjuan Zhang *Shanxi Key Lab for Modernization of TCVM, College of Life Science, Shanxi Agricultural University, Taigu, Shanxi 030801 China.
Yali ZhangShanxi Key Lab for Modernization of TCVM, College of Life Science, Shanxi Agricultural University, Taigu, Shanxi 030801 China.
Yi LiShanxi Key Lab for Modernization of TCVM, College of Life Science, Shanxi Agricultural University, Taigu, Shanxi 030801 China.
Yanbing NiuShanxi Key Lab for Modernization of TCVM, College of Life Science, Shanxi Agricultural University, Taigu, Shanxi 030801 China.
Long PangSchool of Basic Medical Science, Xi'an Medical University, Xi'an, Shaanxi 710021 China.
Jinyi WangCollege of Chemistry and Pharmacy, Northwest A&F University, Yangling, Shaanxi 712100 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isolation and manipulation of single cells play a crucial role in drug screening. However, previously reported single-cell drug screening lacked multiple-dose concentration gradient studies, which limits their ability to predict drug performance accurately. To solve this problem, we constructed a multiconcentration gradient generator in which a Tai Chi-spiral mixer can accelerate solution mixing in a short time and produce a linear concentration gradient. Later, a gradient generator combined with a single-cell capture array was adopted to investigate the effects of single or combined doses of 5-fluorouracil and cisplatin on human hepatoma cells and human breast carcinoma cells (at the single-cell level). The results showed that both drugs were effective in inhibiting the growth of cancer cells, and the combination was more effective for human hepatoma cells. In addition, the relationship between the biomechanical heterogeneity (e.g., deformability and size) of tumor cells and potential drug resistance at the single-cell level was investigated, indicating that small and/or deformable cells were more resistant than large and/or less deformable cells. The device provides a simple and reliable platform for studying the optimal dosage of different drug candidates at the single-cell level and effectively screening single-agent chemotherapy regimens and combination therapies.

Indexed as

ChemistryEngineering

Identifiers

PMID37064165
PMCPMC10102073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.